SK Bioscience on Thursday unveiled the new "SKBS 3.0" growth strategy, prioritizing the ...

SK Bioscience Co Ltd chief executive Jaeyong Ahn said in a Financial Times interview that it is unl...

A South Korean company is looking for a business opportunity with partners from the Association of S...

SK bioscience has developed a new vaccine which can line up with AztraZeneca and Pfizer. They devel...

SK Bioscience´s research and development laboratory developed a number of vaccines, such as th...

SK Bioscience said on Tuesday that it has published the first Task Force on Climate-related Financi...

Amid a global expansion push, SK bioscience has unveiled a growth strategy focused on broadening it...

SK Bioscience, which developed Korea´s first COVID-19 vaccine, SKYCovione, said Thursday that...

As SK Bioscience is poised to contribute to the world’s prolonged battle against the COVID-19 pande...

Mr Ahn Jae-yong, CEO of SK Bioscience (SK Bio), was vaccinated using ‘SKYCovione’, the first Korean...

SEOUL -South Korea on Friday authorized the use of SKYCovione, a homegrown COVID-19 vaccine develope...

“The message given to us is clear. We shortened the vaccine development period from 10 years to two...